Alvotech (NASDAQ:ALVOW – Get Free Report) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totaling 1,552 shares, a growth of 64.1% from the December 15th total of 946 shares. Based on an average daily volume of 1,520 shares, the days-to-cover ratio is currently 1.0 days. Based on an average daily volume of 1,520 shares, the days-to-cover ratio is currently 1.0 days.
Alvotech Price Performance
ALVOW opened at $0.51 on Friday. Alvotech has a 12-month low of $0.47 and a 12-month high of $3.77. The business’s fifty day simple moving average is $0.71 and its 200-day simple moving average is $1.18.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Featured Articles
- Five stocks we like better than Alvotech
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- Wall Street Alert: Buy AES
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
